Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting
PeerJ · 27.03.2026 · 14 · e21020
DOI: 10.7717/peerj.21020 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PeerJ, online erschienen am 27.03.2026. Verfasst von Sijie Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Aspirin, Gout, Uric Acid, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Guangdong Province.
Abstract (Originalsprache)
Objective
This retrospective study compared the effects of indobufen versus aspirin, each combined with clopidogrel, on serum uric acid (SUA) levels and gout attacks in patients undergoing coronary stenting.
Methods
Among 213 enrolled patients, 156 were included after propensity score matching and assigned to either the indobufen plus clopidogrel group ( n = 78) or the aspirin plus clopidogrel group ( n = 78). SUA levels were measured at baseline and at the 1-month, 6-month, and 1-year follow-ups. Gout attacks and major cardiovascular events were recorded throughout the study.
Results
Baseline characteristics were comparable. The indobufen group showed significant reductions in SUA levels at all follow-ups (all, P < 0.001), whereas levels in the aspirin group remained stable. Although the initial gout attack rates at baseline were similar between groups, the probability of recurrence during follow-up was lower in the indobufen group. Cardiovascular safety profiles were comparable between groups.
Conclusion
Indobufen plus clopidogrel significantly reduced SUA levels and showed a favorable trend in reducing gout recurrences without compromising cardiovascular safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- UNSW Microbiome Research Centre, St George and Sutherland Clinical Campus, University of New South Wales, Sydney, Australia.
- School of Medicine, Huaqiao University, Quanzhou, China.
Förderung
- Science and Technology Program of Guangdong Province
Zitieren
APA
Jiang, S., Lin, L., Duan, X., Zhang, J., Hou, Y., Gong, L., Zeng, Q., & Zheng, H. (2026). Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting. PeerJ, 14, e21020. https://doi.org/10.7717/peerj.21020
Vancouver
Jiang S, Lin L, Duan X, Zhang J, Hou Y, Gong L, et al. Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting. PeerJ. 2026;14:e21020. doi:10.7717/peerj.21020
BibTeX
@article{Jiang2026,
author = {Jiang, Sijie and Lin, Lilong and Duan, Xiaolin and Zhang, Jianqin and Hou, Yuqing and Gong, Lan and Zeng, Qingchun and Zheng, Hua},
title = {Indobufen versus aspirin in dual antiplatelet therapy: a retrospective study of effects on serum uric acid levels and gout attacks in patients post-coronary stenting},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e21020},
doi = {10.7717/peerj.21020}
}
EUVIMED